Loading... (0%)
About liver disease

GENFIT: A COMPREHENSIVE APPROACH TO NASH

NIS4: Our blood-based diagnostic test for the identification of patients with NASH...
LEARN MORE
Health prevention, medical education, dissemination of information related to NASH...
ACCESS WEBSITE

COMPANY LIFE

We are a late-stage biopharmaceutical company dedicated to high unmet medical needs.
Learn more
Find out our about current job opportunities or submit your spontaneous application explaining your project.
LEARN MORE

DOCUMENTATION

Update on Corporate Governance

Joint interview: Jean-François Mouney, Co-founder, CEO, Chairman of the Board; Pascal Prigent, Future CEO; Dean Hum, Chief Operating Officer & Chief Scientific Officer

 

Read “Update on Corporate Governance”

Press releases
  • GENFIT: Upcoming Investor Events
    10/07/2019
  • GENFIT: H1 2019 Results and R&D Pipeline Progression
    09/30/2019
  • GENFIT Reinforces Corporate Leadership in the U.S.
    09/26/2019
  • GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
    09/09/2019
  • GENFIT: Board of Directors, Represented by Chairman Jean-François Mouney, Appoints Pascal Prigent as New CEO
    09/02/2019
Events
Phasellus mattis ultricies Praesent nunc commodo venenatis, eleifend dolor odio eget